TherapeuticsMD, Inc. $TXMD

What the company doesAI summary of filing

TherapeuticsMD, Inc. is a royalty-generating company that receives revenues from licensing agreements for hormone therapy pharmaceutical products, primarily IMVEXXY and BIJUVA, which are commercialized by licensees including Mayne Pharma, Knight, and Theramex in various markets. The company generates income through royalties on product sales rather than direct product sales, and its revenues depend on licensees' ability to manufacture, distribute, and promote these products through their sales forces and distribution channels. The company faces competition from generic drug manufacturers, with ongoing patent litigation involving Teva Pharmaceuticals and Sun Pharma regarding IMVEXXY, and it relies on its licensees and patent protections to maintain royalty streams. As of December 31, 2025, the company operates with one employee and uses external consultants, operating as a royalty-stage revenue-generating business following its transition from active pharmaceutical development. [10-K 2026-03-30]

Segments: IMVEXXY, BIJUVA, ANNOVERA